Emergent Biosolutions Inc stock is traded at $5.85, with a volume of 1,568,779. It is down -0.85% in the last 24 hours and down -19.20% over the past month. Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.
Previous Close:
$5.90
Open:
$5.91
24h Volume:
1,568,779
Relative Volume:
1.22
Market Cap:
$300.78M
Revenue:
$676.80M
Net Income/Loss:
-$8.60M
P/E Ratio:
-
EPS:
-$0.2829
Net Cash Flow:
$135.40M
1W Performance:
-18.98%
1M Performance:
-19.20%
6M Performance:
-35.36%
1Y Performance:
-43.42%
1-Day Range:
$5.80$6.05
1-Week Range:
$5.51$7.22
52-Week Range:
$4.36$14.06
Emergent Biosolutions Inc Stock (EBS) Company Profile
Name
Emergent Biosolutions IncSector
HealthcarePhone
240-631-3200Address
300 PROFESSIONAL DR, GAITHERSBURG, MD, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS